Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study von Joly, Florence, Fabbro, Michel, Berton, Dominique, Lequesne, Justine, Anota, Amélie, Puszkiel, Alicja, Floquet, Anne, Vegas, Hélène, Bourgeois, Hugues, Bengrine Lefevre, Leïla, You, Benoît, Pommeret, Fanny, Lortholary, Alain, Spaeth, Dominique, Hardy-Bessard, Anne-Claire, Abdeddaim, Cyril, Kaminsky-Forrett, Marie-Christine, Tod, Michel, Kurtz, Jean-Emmanuel, Del Piano, Francesco, Meunier, Jérôme, Raban, Nadia, Alexandre, Jérome, Mouret-Reynier, Marie-Ange, Ray-Coquard, Isabelle, Provansal Gross, Magali, Brachet, Pierre-Emmanuel

Volltext